Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection

{ 'indexed': {'date-parts': [[2024, 5, 13]], 'date-time': '2024-05-13T16:04:48Z', 'timestamp': 1715616288719}, 'reference-count': 35, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2020, 9, 1]], 'date-time': '2020-09-01T00:00:00Z', 'timestamp': 1598918400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 9]]}, 'DOI': '10.1016/j.mehy.2020.109783', 'type': 'journal-article', 'created': {'date-parts': [[2020, 4, 27]], 'date-time': '2020-04-27T17:53:10Z', 'timestamp': 1588009990000}, 'page': '109783', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 39, 'title': 'Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms ' 'after SARS-CoV-2 infection', 'prefix': '10.1016', 'volume': '142', 'author': [ {'given': 'A.', 'family': 'Klimke', 'sequence': 'first', 'affiliation': []}, {'given': 'G.', 'family': 'Hefner', 'sequence': 'additional', 'affiliation': []}, {'given': 'B.', 'family': 'Will', 'sequence': 'additional', 'affiliation': []}, {'given': 'U.', 'family': 'Voss', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.mehy.2020.109783_b0005', 'unstructured': 'https://coronavirus.jhu.edu/map.html, downloaded April 3, 2020).'}, { 'key': '10.1016/j.mehy.2020.109783_b0010', 'unstructured': 'Novel, C. P. E. R. E. (2020). The epidemiological characteristics of an ' 'outbreak of 2019 novel coronavirus diseases (COVID-19) in China. ' 'Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi, 41(2), ' '145.'}, { 'key': '10.1016/j.mehy.2020.109783_b0015', 'doi-asserted-by': 'crossref', 'unstructured': 'Wu, Z., & McGoogan, J. M. (2020). Characteristics of and important ' 'lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: ' 'summary of a report of 72 314 cases from the Chinese Center for Disease ' 'Control and Prevention. Jama.', 'DOI': '10.1001/jama.2020.2648'}, { 'key': '10.1016/j.mehy.2020.109783_b0020', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/S1473-3099(20)30195-X', 'article-title': 'Real estimates of mortality following COVID-19 infection', 'author': 'Baud', 'year': '2020', 'journal-title': 'Lancet Infect Dis'}, { 'key': '10.1016/j.mehy.2020.109783_b0025', 'doi-asserted-by': 'crossref', 'unstructured': 'Hamer, O. W., Salzberger, B., Gebauer, J., Stroszczynski, C., & Pfeifer, ' 'M. (2020, March). CT morphology of COVID-19: Case report and review of ' 'literature. In RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und ' 'der bildgebenden Verfahren. © Georg Thieme Verlag KG.', 'DOI': '10.1055/a-1142-4094'}, { 'key': '10.1016/j.mehy.2020.109783_b0030', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/S0140-6736(20)30566-3', 'article-title': 'Clinical course and risk factors for mortality of adult inpatients with ' 'COVID-19 in Wuhan, China: a retrospective cohort study', 'author': 'Zhou', 'year': '2020', 'journal-title': 'The Lancet'}, { 'key': '10.1016/j.mehy.2020.109783_b0035', 'doi-asserted-by': 'crossref', 'DOI': '10.1056/NEJMoa2001282', 'article-title': 'A trial of lopinavir–ritonavir in adults hospitalized with severe ' 'Covid-19', 'author': 'Cao', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.mehy.2020.109783_b0040', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105924', 'article-title': 'Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona ' 'virus disease-2019 (COVID- 19): the epidemic and the challenges', 'author': 'Lai', 'year': '2020', 'journal-title': 'Int J Antimicrobial Agents'}, { 'issue': '1', 'key': '10.1016/j.mehy.2020.109783_b0045', 'doi-asserted-by': 'crossref', 'first-page': '58', 'DOI': '10.5582/ddt.2020.01012', 'article-title': 'Discovering drugs to treat coronavirus disease 2019 (COVID-19)', 'volume': '14', 'author': 'Dong', 'year': '2020', 'journal-title': 'Drug Discover Therapeut'}, { 'key': '10.1016/j.mehy.2020.109783_b0050', 'article-title': 'Chloroquine and hydroxychloroquine as available weapons to fight ' 'COVID-19', 'volume': '105932', 'author': 'Colson', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.mehy.2020.109783_b0055', 'doi-asserted-by': 'crossref', 'unstructured': 'Gao, J., Tian, Z., & Yang, X. (2020). Breakthrough: Chloroquine ' 'phosphate has shown apparent efficacy in treatment of COVID-19 ' 'associated pneumonia in clinical studies. Bioscience trends.', 'DOI': '10.5582/bst.2020.01047'}, { 'key': '10.1016/j.mehy.2020.109783_b0060', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID- 19: ' 'results of an open-label non-randomized clinical trial', 'volume': '105949', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '1', 'key': '10.1016/j.mehy.2020.109783_b0065', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.5582/bst.2020.01020', 'article-title': 'Drug treatment options for the 2019-new coronavirus (2019-nCoV)', 'volume': '14', 'author': 'Lu', 'year': '2020', 'journal-title': 'Biosci Trends'}, { 'issue': '3', 'key': '10.1016/j.mehy.2020.109783_b0070', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'key': '10.1016/j.mehy.2020.109783_b0075', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/cid/ciaa237', 'article-title': 'In vitro antiviral activity and projection of optimized dosing design ' 'of hydroxychloroquine for the treatment of severe acute respiratory ' 'syndrome coronavirus 2 (SARS-CoV-2)', 'author': 'Yao', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.mehy.2020.109783_b0080', 'series-title': 'Chloroquine. In StatPearls [Internet]', 'author': 'Goel', 'year': '2019'}, { 'issue': '1', 'key': '10.1016/j.mehy.2020.109783_b0085', 'doi-asserted-by': 'crossref', 'first-page': '40', 'DOI': '10.1097/00004714-198202000-00005', 'article-title': 'Lethality and behavioral side effects of chloroquine', 'volume': '2', 'author': 'Good', 'year': '1982', 'journal-title': 'J Clin Psychopharmacol'}, { 'issue': '3', 'key': '10.1016/j.mehy.2020.109783_b0090', 'doi-asserted-by': 'crossref', 'first-page': '359', 'DOI': '10.1016/j.rdc.2019.04.008', 'article-title': 'Are the Current Recommendations for Chloroquine and Hydroxychloroquine ' 'Screening Appropriate?', 'volume': '45', 'author': 'Schwartzman', 'year': '2019', 'journal-title': 'Rheumatic Dis Clinics'}, { 'issue': '1', 'key': '10.1016/j.mehy.2020.109783_b0095', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1007/s10557-018-06847-9', 'article-title': 'Revisiting the Cardiotoxic Effect of Chloroquine', 'volume': '33', 'author': 'Blignaut', 'year': '2019', 'journal-title': 'Cardiovasc Drugs Ther'}, { 'issue': '3', 'key': '10.1016/j.mehy.2020.109783_b0100', 'doi-asserted-by': 'crossref', 'first-page': '345', 'DOI': '10.1002/cpt1979253345', 'article-title': 'Chloroquine serum concentration and side effects: Evidence for ' 'dose-dependent kinetics', 'volume': '25', 'author': 'Frisk-Holmberg', 'year': '1979', 'journal-title': 'Clin Pharmacol Ther'}, { 'key': '10.1016/j.mehy.2020.109783_b0105', 'unstructured': 'https://www.pharmazeutische-zeitung.de/virologe-drosten-nimmt-stellung-zu-chloroquin; ' 'downloaded 04.02.2020.'}, { 'key': '10.1016/j.mehy.2020.109783_b0110', 'doi-asserted-by': 'crossref', 'unstructured': 'Chen, I. Y., Moriyama, M., Chang, M. F., & Ichinohe, T. (2019). Severe ' 'acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 ' 'inflammasome. Front Microbiol, 10.', 'DOI': '10.3389/fmicb.2019.00050'}, { 'key': '10.1016/j.mehy.2020.109783_b0115', 'unstructured': 'Chen Y. Adjunctive Corticosteroid Therapy for Patients with Severe Novel ' 'Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial. ' 'http://www.chictr.org.cn/showproj.aspx?proj=48777 [Accessed 03 April ' '2020].'}, { 'issue': '20', 'key': '10.1016/j.mehy.2020.109783_b0120', 'doi-asserted-by': 'crossref', 'first-page': '1405', 'DOI': '10.1056/NEJM199711133372001', 'article-title': 'Effect of inhaled formoterol and budesonide on exacerbations of asthma', 'volume': '337', 'author': 'Pauwels', 'year': '1997', 'journal-title': 'N Engl J Med'}, { 'issue': '8', 'key': '10.1016/j.mehy.2020.109783_b0125', 'doi-asserted-by': 'crossref', 'first-page': '580', 'DOI': '10.1136/thx.36.8.580', 'article-title': 'Effect of aerosol and oral fenoterol on histamine and methacholine ' 'challenge in asthmatic subjects', 'volume': '36', 'author': 'Salome', 'year': '1981', 'journal-title': 'Thorax'}, { 'issue': '1', 'key': '10.1016/j.mehy.2020.109783_b0130', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.2165/00003088-199936001-00001', 'article-title': 'Pharmacokinetics of zanamivir after intravenous, oral, inhaled or ' 'intranasal administration to healthy volunteers', 'volume': '36', 'author': 'Cass', 'year': '1999', 'journal-title': 'Clin Pharmacokinet'}, { 'key': '10.1016/j.mehy.2020.109783_b0135', 'doi-asserted-by': 'crossref', 'unstructured': 'Qiu, R., Wei, X., Zhao, M., et al. (2020). Outcome reporting from ' 'protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a ' 'review. medRxiv.', 'DOI': '10.1101/2020.03.04.20031401'}, { 'issue': '2', 'key': '10.1016/j.mehy.2020.109783_b0140', 'first-page': '1', 'article-title': 'COVID-19: perspectives on the potential novel global threat', 'volume': '15', 'author': 'Gentile', 'year': '2020', 'journal-title': 'Rev Recent Clinic Trials'}, { 'issue': '23', 'key': '10.1016/j.mehy.2020.109783_b0145', 'doi-asserted-by': 'crossref', 'first-page': '14614', 'DOI': '10.1128/JVI.79.23.14614-14621.2005', 'article-title': 'ACE2 receptor expression and severe acute respiratory syndrome ' 'coronavirus infection depend on differentiation of human airway ' 'epithelia', 'volume': '79', 'author': 'Jia', 'year': '2005', 'journal-title': 'J Virol'}, { 'key': '10.1016/j.mehy.2020.109783_b0150', 'unstructured': 'Zhang Z. Therapeutic effect of hydroxychloroquine on novel coronavirus ' 'pneumonia (COVID-19). http://www.chictr.org.cn/showproj.aspx?proj=48880 ' '[Accessed 14 Feb 2020].'}, { 'key': '10.1016/j.mehy.2020.109783_b0155', 'doi-asserted-by': 'crossref', 'unstructured': 'Su, Z., & Wu, Y. (2020). A Multiscale and Comparative Model for Receptor ' 'Binding of 2019 Novel Coronavirus and the Implication of its Life Cycle ' 'in Host Cells. bioRxiv.', 'DOI': '10.1101/2020.02.20.958272'}, { 'key': '10.1016/j.mehy.2020.109783_b0160', 'doi-asserted-by': 'crossref', 'unstructured': 'Devaux, C. A., Rolain, J. M., Colson, P., & Raoult, D. (2020). New ' 'insights on the antiviral effects of chloroquine against coronavirus: ' 'what to expect for COVID-19?. Int J Antimicrobial Agents, 105938.', 'DOI': '10.1016/j.ijantimicag.2020.105938'}, { 'key': '10.1016/j.mehy.2020.109783_b0165', 'doi-asserted-by': 'crossref', 'unstructured': 'Kearney, J. (2020). Chloroquine as a Potential Treatment and Prevention ' 'Measure for the 2019 Novel Coronavirus: A Review.', 'DOI': '10.20944/preprints202003.0275.v1'}, { 'issue': '1', 'key': '10.1016/j.mehy.2020.109783_b0170', 'doi-asserted-by': 'crossref', 'first-page': '264', 'DOI': '10.1016/j.bbrc.2004.08.085', 'article-title': 'In vitro inhibition of severe acute respiratory syndrome coronavirus by ' 'chloroquine', 'volume': '323', 'author': 'Keyaerts', 'year': '2004', 'journal-title': 'Biochem Biophys Res Commun'}, { 'issue': '3', 'key': '10.1016/j.mehy.2020.109783_b0175', 'doi-asserted-by': 'crossref', 'first-page': '235', 'DOI': '10.1093/rheumatology/33.3.235', 'article-title': 'Bioavalibility of hydroxychlorquine tablets in patients with rheumatoid ' 'arthritis', 'volume': '33', 'author': 'McLachlan', 'year': '1994', 'journal-title': 'Rheumatology'}], 'container-title': 'Medical Hypotheses', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0306987720307076?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0306987720307076?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2020, 10, 6]], 'date-time': '2020-10-06T21:02:08Z', 'timestamp': 1602018128000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0306987720307076'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 9]]}, 'references-count': 35, 'alternative-id': ['S0306987720307076'], 'URL': 'http://dx.doi.org/10.1016/j.mehy.2020.109783', 'relation': { 'has-preprint': [ { 'id-type': 'doi', 'id': '10.20944/preprints202004.0090.v1', 'asserted-by': 'object'}]}, 'ISSN': ['0306-9877'], 'subject': [], 'container-title-short': 'Medical Hypotheses', 'published': {'date-parts': [[2020, 9]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe ' 'clinical symptoms after SARS-CoV-2 infection', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Medical Hypotheses', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.mehy.2020.109783', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 Elsevier Ltd. All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '109783'}